{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"}],"units":"Participants"}],"description":"The Primary Outcome is: the incidence of renal allograft rejection at 6 months post-transplant","groups":[{"description":"Single arm combined bone marrow and kidney transplantation\n\nTacrolimus: Tacrolimus starting on Day -1\n\nEquine Anti-thymocyte globulin: 20 mg/kg IV on Days -3, -1, +1, +3\n\nKidney transplant from a related donor: On Day 0 the renal transplant is performed according to standard surgical techniques.\n\nBone marrow transplant from a related donor: Donor bone marrow (\\> 2 x 10e8 nucleated cells/kg of recipient body weight) is prepared for infusion according to the standard procedure. The infusion begins in the operating room as soon as the vascular anastomosis of the renal allograft has been completed.\n\nTotal body irradiation 400 centigray (200 cGy X 2): On transplant day -1","id":"OG000","title":"Bone Marrow and Kidney RECIPIENTS"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"One bone marrow/kidney transplant recipient was enrolled and treated on this trial.","reportingStatus":"POSTED","timeFrame":"6 Months","title":"Number of Participants Without Renal Allograft Rejection at 6 Months Post-transplant","type":"PRIMARY","unitOfMeasure":"Participants"}